Mercer R J, Bryan R M, Bennett R C
Aust N Z J Surg. 1984 Jun;54(3):215-8. doi: 10.1111/j.1445-2197.1984.tb05305.x.
Hormone receptor assays were performed on specimens of breast cancer from 19 male patients over a six year period. Ninety-four per cent were positive for oestrogen receptor, 93% for progesterone receptor and 57% for androgen receptor. Eight patients had hormonal treatment for advanced disease and five (62.5%) responded. Duration of response ranged from six months to 23 months. There appeared to be no clear relationship between hormone receptor status or quantitative receptor level and response to treatment in this small series. It is unlikely that oestrogen and progesterone receptors will be of value as discriminators because of their high incidence and it is suggested that further study of androgen receptor is indicated.
在六年时间里，对19例男性乳腺癌患者的标本进行了激素受体检测。94%的患者雌激素受体呈阳性，93%的患者孕激素受体呈阳性，57%的患者雄激素受体呈阳性。8例晚期疾病患者接受了激素治疗，其中5例（62.5%）有反应。反应持续时间从6个月到23个月不等。在这个小样本系列中，激素受体状态或定量受体水平与治疗反应之间似乎没有明显关系。由于雌激素和孕激素受体的高发生率，它们作为鉴别指标的价值不大，建议对雄激素受体进行进一步研究。
